A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation

Agnieszka Pozarska (Giessen, Germany), Agnieszka Pozarska, Gero Niess, Werner Seeger, Rory Morty

Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Session: Common mechanisms in lung development and fibrosis
Session type: Thematic Poster
Number: 4026
Disease area: Paediatric lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Agnieszka Pozarska (Giessen, Germany), Agnieszka Pozarska, Gero Niess, Werner Seeger, Rory Morty. A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation. Eur Respir J 2016; 48: Suppl. 60, 4026

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
TGF-β receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung
Source: Eur Respir J 2008; 32: 285-295
Year: 2008



Wnt11 inhibits effects of transforming growth factor-beta1 (TGFbeta1) on lung epithelial phenotype
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013


Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014

Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

The role of the accessory type III transforming growth factor-β receptors in the regulation of pulmonary vascular development
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011


Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Epidermal growth factor receptor expression in human lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Epidermal growth factor (EGF) and its receptors (ERBBs) in smokers with and without COPD: An index of epithelial repair imbalance?
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


ErbB receptor regulation by dexamethasone in mouse type II epithelial cells
Source: Eur Respir J 2006; 28: 1117-1123
Year: 2006



Role of TGF-β accessory receptors (betaglycan and endoglin) during lung development
Source: Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Year: 2003


Transforming growth factor alpha expression in a transgenic mouse model impairs lung and diaphragm mechanics
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006



Down-regulation of the P2Y12 purinergic receptor expression on human bronchial epithelial cells by transforming growth factor-beta
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016

Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

Oral presentation: Influenza virus (IV) impairs fibroblast growth factor receptor 2b (FGFR2b) dependent epithelial regeneration from a distal epithelial progenitor pool
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014

Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012



Adenovector delivery of transforming growth factor-β (TGF-β) superfamily member, activin A, in the rodent lung
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004